Endovascular Recanalization and Standard Medical Management for Symptomatic Nonacute Intracranial Artery Occlusion Trial

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

453

Participants

Timeline

Start Date

January 1, 2020

Primary Completion Date

October 31, 2024

Study Completion Date

October 31, 2024

Conditions
Intracranial Artery Occlusion With Infarction
Interventions
BIOLOGICAL

endovascular recanalization

to recanalize the occlusion cerebral artery with intravascular intervention

Trial Locations (15)

100029

Beijing Anzhen Hospital, Beijing

100054

Beijing You 'anmen Hospital, Beijing

100070

Beijing Tiantan Hospital, Beijing

102401

Liangxiang Hospital, Beijing

116033

Dalian Municipal Central Hospital, Dalian

130403

Handan Central Hospital, Handan

150603

ORDOS Central Hospital, Ordos

200336

Tong Ren Hospital Shanghai Jiaotong University School of Medicine, Shanghai

214500

Jingjiang people's Hospital, Jingjiang

271000

Tai'an Hospital of Traditional Chinese Medicine, Tai’an

318020

Taizhou first people's Hospital, Taizhou

050055

Hebei Provincial People's Hospital, Shijiazhuang

028000

TongLiao City Hospital, Tongliao

030009

Taiyuan Central Hospital, Taiyuan

030012

Shanxi Provincial People's Hospital, Taiyuan

All Listed Sponsors
lead

Feng Gao

OTHER

NCT04864691 - Endovascular Recanalization and Standard Medical Management for Symptomatic Nonacute Intracranial Artery Occlusion Trial | Biotech Hunter | Biotech Hunter